Dermapharm Holding SE (ETR:DMP)
Germany flag Germany · Delayed Price · Currency is EUR
35.05
-0.15 (-0.43%)
May 21, 2025, 5:35 PM CET

Dermapharm Holding SE Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
1,1991,1951,1501,040959.6807.64
Upgrade
Other Revenue
-2.320.750.420.250.490.67
Upgrade
Revenue
1,1961,1951,1511,041960.09808.31
Upgrade
Revenue Growth (YoY)
5.15%3.89%10.59%8.38%18.78%13.15%
Upgrade
Cost of Revenue
449.46445.6446.6391.85349.87354.42
Upgrade
Gross Profit
746.77749.85704.14648.7610.22453.89
Upgrade
Selling, General & Admin
293.54287.43271.01190.56168.95158.06
Upgrade
Other Operating Expenses
154.66158.18151.21117.7299.68110.13
Upgrade
Operating Expenses
530.6527.78510.99365.98314.31313.77
Upgrade
Operating Income
216.17222.07193.16282.72295.91140.12
Upgrade
Interest Expense
-55.8-58.41-54.97-12.34-8.84-9.36
Upgrade
Interest & Investment Income
2.9513.992.490.334.020.51
Upgrade
Earnings From Equity Investments
1.651.52-7.16-13.540.32-1.5
Upgrade
Currency Exchange Gain (Loss)
1.41.4-1.950.372.28-1.63
Upgrade
Other Non Operating Income (Expenses)
-0.96-0.96-16.63-1.12-0.830.24
Upgrade
EBT Excluding Unusual Items
165.42179.61114.93256.43292.86128.38
Upgrade
Merger & Restructuring Charges
-----0.6-
Upgrade
Impairment of Goodwill
-2.12-2.12--36.45-5.43-
Upgrade
Gain (Loss) on Sale of Investments
-0-0-1.98-9.06-
Upgrade
Gain (Loss) on Sale of Assets
0.630.632.963.131.380.23
Upgrade
Asset Writedown
-6.21-6.21-15.82-7.03-4.48-3.58
Upgrade
Other Unusual Items
--5.78---
Upgrade
Pretax Income
157.81172.01106216.3292.98125.28
Upgrade
Income Tax Expense
55.9560.2745.4683.6884.0739.36
Upgrade
Earnings From Continuing Operations
101.86111.7460.53132.62208.985.93
Upgrade
Minority Interest in Earnings
1.712.051.831.620.68-0.1
Upgrade
Net Income
103.57113.7962.37134.24209.5885.83
Upgrade
Net Income to Common
103.57113.7962.37134.24209.5885.83
Upgrade
Net Income Growth
83.05%82.45%-53.54%-35.95%144.19%11.18%
Upgrade
Shares Outstanding (Basic)
545454545454
Upgrade
Shares Outstanding (Diluted)
545454545454
Upgrade
Shares Change (YoY)
-0.06%-----
Upgrade
EPS (Basic)
1.922.111.162.493.891.59
Upgrade
EPS (Diluted)
1.922.111.162.493.891.59
Upgrade
EPS Growth
83.15%82.45%-53.54%-35.91%144.65%11.19%
Upgrade
Free Cash Flow
131.25163.14177.88249.52189.1790.3
Upgrade
Free Cash Flow Per Share
2.443.033.304.633.511.68
Upgrade
Dividend Per Share
0.9000.9000.8801.0502.1700.880
Upgrade
Dividend Growth
2.27%2.27%-16.19%-51.61%146.59%10.00%
Upgrade
Gross Margin
62.43%62.72%61.19%62.34%63.56%56.15%
Upgrade
Operating Margin
18.07%18.58%16.79%27.17%30.82%17.34%
Upgrade
Profit Margin
8.66%9.52%5.42%12.90%21.83%10.62%
Upgrade
Free Cash Flow Margin
10.97%13.65%15.46%23.98%19.70%11.17%
Upgrade
EBITDA
245.17250.77220.31302.36312.36155.05
Upgrade
EBITDA Margin
20.50%20.98%19.14%29.06%32.53%19.18%
Upgrade
D&A For EBITDA
2928.727.1519.6416.4514.92
Upgrade
EBIT
216.17222.07193.16282.72295.91140.12
Upgrade
EBIT Margin
18.07%18.58%16.79%27.17%30.82%17.34%
Upgrade
Effective Tax Rate
35.45%35.04%42.89%38.69%28.70%31.41%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.